Reimbursement for NHS Mounjaro dispensing confirmed for September 2025 Community Pharmacy England has reached an agreement with the Department of Health and Social Care to ensure that pharmacy owners are not dispensing at a loss.…
Pharmacists found to significantly reduce hospitalisations from heart failure Researchers found that hospital-affiliated or clinic-based pharmacists could help prevent unplanned hospitalisations in high-risk patients with heart failure.…
First home-based digital technologies approved for cardiac rehabilitation The National Institute for Health and Care Excellence said digital technologies could offset the low uptake of traditional cardiac rehabilitation programmes.…
Frailty and the patient journey How to recognise opportunities for medicines optimisation and rationalisation during the course of the patient journey following a frailty-related hospital admission.…
Pharmacy at the frontline of tackling healthcare inequalities This month’s column from the RPS chief scientist’s office looks at highlights from recent pharmacy practice research through the lens of Core20PLUS5.…
Stronger regulatory oversight needed for self-testing kits, review concludes Authors of the cross-sectional review found that nearly three-quarters of over-the-counter testing kits “did not progress or close care pathways”.…
Chronic heart failure deaths could fall by 3,000 per year following updated guidance, says NICE The National Institute for Health and Care Excellence said that drugs are being introduced earlier in patient treatment for chronic heart failure, which has been reflected in its draft guidance.…
Case-based learning: pharmacy involvement in congenital heart disease A comprehensive overview of the journey of a patient with congenital heart disease, from foetal to paediatric care, including perspectives from the parents and the medical team.…
Congenital heart disease: an overview An overview of the causes, diagnosis and treatments for congenital heart disease.…
Antidepressants ‘substantially increase risk’ of low blood pressure when standing up in older people, study results suggest Researchers found that patients aged over 60 years who were prescribed selective serotonin re-uptake inhibitors were at a four-fold increased risk of postural hypotension in first four weeks of use.…
